Characterization of an artificial antigen-presenting cell to propagate cytolytic CD19-specific T cells - PubMed (original) (raw)
Characterization of an artificial antigen-presenting cell to propagate cytolytic CD19-specific T cells
T Numbenjapon et al. Leukemia. 2006 Oct.
No abstract available
Similar articles
- Development and application of CD19-specific T cells for adoptive immunotherapy of B cell malignancies.
Cooper LJ, Al-Kadhimi Z, DiGiusto D, Kalos M, Colcher D, Raubitschek A, Forman SJ, Jensen MC. Cooper LJ, et al. Blood Cells Mol Dis. 2004 Jul-Aug;33(1):83-9. doi: 10.1016/j.bcmd.2004.03.003. Blood Cells Mol Dis. 2004. PMID: 15223016 Review. - Engineering GVL through T cell gene transfer.
Jensen MC. Jensen MC. Biol Blood Marrow Transplant. 2008 Jan;14(1 Suppl 1):5. doi: 10.1016/j.bbmt.2007.10.011. Biol Blood Marrow Transplant. 2008. PMID: 18162214 No abstract available. - Combining adoptive cellular and immunocytokine therapies to improve treatment of B-lineage malignancy.
Singh H, Serrano LM, Pfeiffer T, Olivares S, McNamara G, Smith DD, Al-Kadhimi Z, Forman SJ, Gillies SD, Jensen MC, Colcher D, Raubitschek A, Cooper LJ. Singh H, et al. Cancer Res. 2007 Mar 15;67(6):2872-80. doi: 10.1158/0008-5472.CAN-06-2283. Cancer Res. 2007. PMID: 17363611 - CARTs to the rescue: therapeutic potential of chimeric antigen receptor T-cells in patients with B-cell malignancies.
Tam CS. Tam CS. Leuk Lymphoma. 2013 Feb;54(2):215-6. doi: 10.3109/10428194.2012.727417. Epub 2012 Sep 28. Leuk Lymphoma. 2013. PMID: 22950939 No abstract available. - CAR T cells: driving the road from the laboratory to the clinic.
Cheadle EJ, Gornall H, Baldan V, Hanson V, Hawkins RE, Gilham DE. Cheadle EJ, et al. Immunol Rev. 2014 Jan;257(1):91-106. doi: 10.1111/imr.12126. Immunol Rev. 2014. PMID: 24329792 Review.
Cited by
- Artificial antigen-presenting cells: the booster for the obtaining of functional adoptive cells.
Li J, Zhou W, Wang W. Li J, et al. Cell Mol Life Sci. 2024 Aug 31;81(1):378. doi: 10.1007/s00018-024-05412-y. Cell Mol Life Sci. 2024. PMID: 39215816 Free PMC article. Review. - GMP-Compliant Universal Antigen Presenting Cells (uAPC) Promote the Metabolic Fitness and Antitumor Activity of Armored Cord Blood CAR-NK Cells.
Liu E, Ang SOT, Kerbauy L, Basar R, Kaur I, Kaplan M, Li L, Tong Y, Daher M, Ensley EL, Uprety N, Nunez Cortes AK, Yang RZ, Li Y, Shaim H, Reyes Silva F, Lin P, Mohanty V, Acharya S, Shanley M, Muniz-Feliciano L, Banerjee PP, Chen K, Champlin RE, Shpall EJ, Rezvani K. Liu E, et al. Front Immunol. 2021 Feb 26;12:626098. doi: 10.3389/fimmu.2021.626098. eCollection 2021. Front Immunol. 2021. PMID: 33717142 Free PMC article. - Manufacture of T cells using the Sleeping Beauty system to enforce expression of a CD19-specific chimeric antigen receptor.
Singh H, Moyes JS, Huls MH, Cooper LJ. Singh H, et al. Cancer Gene Ther. 2015 Mar;22(2):95-100. doi: 10.1038/cgt.2014.69. Epub 2015 Jan 16. Cancer Gene Ther. 2015. PMID: 25591810 Review. - Activating and propagating polyclonal gamma delta T cells with broad specificity for malignancies.
Deniger DC, Maiti SN, Mi T, Switzer KC, Ramachandran V, Hurton LV, Ang S, Olivares S, Rabinovich BA, Huls MH, Lee DA, Bast RC Jr, Champlin RE, Cooper LJ. Deniger DC, et al. Clin Cancer Res. 2014 Nov 15;20(22):5708-19. doi: 10.1158/1078-0432.CCR-13-3451. Epub 2014 May 15. Clin Cancer Res. 2014. PMID: 24833662 Free PMC article. - Human cell-based artificial antigen-presenting cells for cancer immunotherapy.
Butler MO, Hirano N. Butler MO, et al. Immunol Rev. 2014 Jan;257(1):191-209. doi: 10.1111/imr.12129. Immunol Rev. 2014. PMID: 24329798 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources